BusinessSanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema TreatmentBy Riza DagocJan 23, 2026, 7:26 AM UTC
GovernanceU.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and InvestorsBy Riza DagocJan 22, 2026, 6:25 AM UTC
GovernanceFDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy ConcernsBy Riza DagocJan 16, 2026, 2:45 AM UTC
BusinessSanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease PortfolioBy Riza DagocJan 15, 2026, 7:02 AM UTC
BusinessMerck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030sBy Riza DagocJan 13, 2026, 2:34 AM UTC
HealthViking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug MarketBy Riza DagocJan 13, 2026, 2:24 AM UTC
LawFederal Appeals Court Blocks Trump-Era Hospital Drug Rebate PlanBy Riza DagocJan 8, 2026, 2:48 AM UTC
BusinessNovo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive PricingBy Riza DagocJan 6, 2026, 2:27 AM UTC
